Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD), ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), is a liver disease worldwide without approved therapeutic drugs. Anti-inflammatory and hepatoprotective drug bicyclol and multi-pharmacological active drug berberine, respectively, have sh...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Hu Li, Nan-Nan Liu, Jian-Rui Li, Biao Dong, Mei-Xi Wang, Jia-Li Tan, Xue-Kai Wang, Jing Jiang, Lei Lei, Hong-Ying Li, Han Sun, Jian-Dong Jiang, Zong-Gen Peng
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-02-01
Serie:	Frontiers in Pharmacology
Soggetti:	nonalcoholic fatty liver disease bicyclol berberine combination lipid metabolism gut microbiota
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2022.843872/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!